Browse every story filed under this topic, curated from trusted publishers around the world.
Mark Cuban’s Cost Plus Drugs lands Eliquis deal
Bristol Myers Squibb and Pfizer will offer Eliquis through Mark Cuban Cost Plus Drug Company, expanding access for cash-paying patients. Beginning April 27, patients with a prescription can purchase a 30-day supply of the drug on …
Read full story →Pfizer's cost-cutting push reaches Ireland again as it plans manufacturing layoffs
During Pfizer's right-sizing push after the COVID-19 pandemic, the company's multibillion-dollar cost-cutting campaign has affected its Ireland operations in several …
Pfizer drafts Fernando Mendoza as new face of its ‘game of inches’ cancer campaign
Pfizer is kicking off the next stage of its cancer awareness program by teaming up with quarterback Fernando Mendoza.
Pfizer's strategy head Andrew Baum to step down following brief tenure: reports
Pfizer's chief strategy and innovation officer Andrew Baum is stepping down merely two years into the role, according to reports.
STAT+: Kelonia Therapeutics’ road from floundering to $3 billion
BioAge bets on inflammation, a short Pfizer career, and more biotech news from The Readout
Pfizer and Astellas secure FDA priority review for Padcev MIBC combo therapy
Pfizer and Astellas have received FDA acceptance for priority review of their sBLA for perioperative Padcev combined with Keytruda for …
STAT+: Former banker brought on to revitalize Pfizer’s strategy departs his post
Pfizer executive Andrew Baum, a former Citi analyst, has left his role as an executive vice president and chief strategy …
You've seen all articles for #pfizer.
Check back
soon
for new stories.